Eli Lilly & Company

FDA Regulatory Profile

Eli Lilly & Company has 5 FDA recalls (1 Class I), 36 inspections, 9 510(k) clearances and 3 compliance actions on record.

What these totals cover: FDA records filed under the name "Eli Lilly & Company" and its spelling variants "Eli Lilly And", "Eli Lilly And Company". Records filed under related names are not included; see Related names.

Latest recall
D-0445-2024 · Class II · Mar 12, 2024
Latest inspection
Jan 9, 2026 · NAI
Latest 510(k)
Sep 16, 2022

Reviewing Eli Lilly & Company as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Eli Lilly & Company yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls5 (1 Class I)Nov 8, 2026File dated Nov 3, 2026Current
510(k) clearances9Nov 8, 2026File dated Nov 2, 2026Current
Inspections36Nov 13, 2026Newest record Nov 5, 2026Current
Compliance actions3Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Eli Lilly & Company's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Eli Lilly & Company: FDA inspections per year 2017: 3 inspections320172018: 1 inspections120182019: 2 inspections220192020: 2 inspections220202021: 1 inspections120212022: 2 inspections220222023: 2 inspections220232024: 1 inspections120242025: 3 inspections320252026: 1 inspections12026
YearInspectionsOAIWarning lettersRecall recordsClass I
202610000
202530300
202410010
202320000
202220000
202110031
202020000
201920000
201810010
201730000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Recent recalls

5 recall records from Nov 8, 2018 to Mar 12, 2024.

NumberClassProductDate
D-0445-2024Class IISterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human…Mar 12, 2024
D-0009-2022Class IGlucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for…Sep 24, 2021
D-0773-2021Class IITrulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company…Aug 19, 2021
D-0720-2021Class IIZyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by…Jun 29, 2021
D-0248-2019Class IIIERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use vial, Rx only…Nov 8, 2018

Recent FDA inspections

36 inspections from Feb 25, 2009 to Jan 9, 2026. Showing the 20 most recent. View all 36 inspections

DateSiteProductClassificationFEI
Jan 9, 2026Indianapolis, INDrugsNo Action Indicated (NAI)1819470
May 20, 2025Indianapolis, INDrugsVoluntary Action Indicated (VAI)1819470
Mar 27, 2025Indianapolis, INDrugsVoluntary Action Indicated (VAI)1819470
Jan 15, 2025Indianapolis, INDrugsNo Action Indicated (NAI)1819470
Nov 26, 2024Concord, NCDevicesVoluntary Action Indicated (VAI)3027403675
Sep 15, 2023Indianapolis, INDrugsVoluntary Action Indicated (VAI)1819470
May 18, 2023Indianapolis, INDevicesNo Action Indicated (NAI)1819470
Sep 30, 2022Indianapolis, INDrugsNo Action Indicated (NAI)1819470
Jan 13, 2022Indianapolis, INDrugsVoluntary Action Indicated (VAI)1819470
Mar 16, 2021Indianapolis, INDrugsVoluntary Action Indicated (VAI)1819470
Mar 20, 2020Indianapolis, INDrugsNo Action Indicated (NAI)1819470
Jan 17, 2020Indianapolis, INDrugsNo Action Indicated (NAI)1819470
Mar 5, 2019Indianapolis, INDevicesNo Action Indicated (NAI)1819470
Jan 25, 2019Indianapolis, INDrugsNo Action Indicated (NAI)1819470
Apr 23, 2018Indianapolis, INDrugsVoluntary Action Indicated (VAI)1819470
Oct 6, 2017Indianapolis, INDevicesNo Action Indicated (NAI)1819470
Jul 28, 2017Indianapolis, INDrugsNo Action Indicated (NAI)1819470
May 25, 2017Indianapolis, INDrugsNo Action Indicated (NAI)1819470
Jul 20, 2016Indianapolis, INDrugsNo Action Indicated (NAI)1819470
Jun 10, 2016Indianapolis, INDrugsNo Action Indicated (NAI)1819470
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 3 compliance actions under Eli Lilly & Company: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Sep 9, 2025.

Individual actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

3 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 1819470Indianapolis, IN34Jan 9, 2026
FEI 3027403675Concord, NC1Nov 26, 2024
FEI 1250046Enfield, CT1Feb 25, 2009

Recent 510(k) clearances

9 510(k) clearances from Sep 25, 1998 to Sep 16, 2022.

K-NumberDeviceDate
K212217Tempo Smart ButtonSep 16, 2022
K160949Go Dose SystemDec 22, 2016
K160668HumaPen SavvioJun 3, 2016
K151686HumanPen Ergo IIDec 30, 2015
K142518HumaPen LuxuraJun 5, 2015
K100988HUMAPEN LUXURA HDAug 17, 2010
K063151HUMAPEN LUXURA HDJan 9, 2007
K053563HUMAPEN MEMOIRApr 7, 2006
K982842HUMAPEN AND HUMAPEN ERGOSep 25, 1998

Need more than this page shows? Ask about Eli Lilly & Company in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.